butaclamol has been researched along with Hyperplasia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jervois, PM; Menadue, MF; Pederick, HJ; Willoughby, JO | 1 |
1 other study(ies) available for butaclamol and Hyperplasia
| Article | Year |
|---|---|
Sustained oestrogen-induced hyperprolactinaemia results from a pituitary defect.
Topics: Animals; Apomorphine; Butaclamol; Estradiol; Fenfluramine; Hyperplasia; Male; Pituitary Gland; Prolactin; Rats; Thyrotropin-Releasing Hormone | 1983 |